Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies
Authors
Keywords
HPV, E proteins, Cervical cancer, Signaling pathways, Therapeutic targets, Molecular mechanisms
Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 174, Issue -, Pages 103675
Publisher
Elsevier BV
Online
2022-04-04
DOI
10.1016/j.critrevonc.2022.103675
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural and biochemical analysis of the PTPN4 PDZ domain bound to the C-terminal tail of the human papillomavirus E6 oncoprotein
- (2022) Hye Seon Lee et al. JOURNAL OF MICROBIOLOGY
- Loss of the E6AP ubiquitin ligase induces p53-dependent phosphorylation of HPV-18 E6 in cells derived from cervical cancer
- (2022) Arushi Vats et al. JOURNAL OF VIROLOGY
- Targeted Disruption of E6/p53 Binding Exerts Broad Activity and Synergism with Paclitaxel and Topotecan against HPV-Transformed Cancer Cells
- (2022) Marta Celegato et al. Cancers
- Dynamic crosstalk within the tumor microenvironment of uterine cervical carcinoma: baseline network, iatrogenic alterations, and translational implications
- (2021) Rosalba De Nola et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Human papillomavirus E6 and E7: What remains?
- (2021) Arushi Vats et al. Tumour Virus Research
- Gene knock-out chain reaction enables high disruption efficiency of HPV18 E6/E7 genes in cervical cancer cells
- (2021) Rui Tian et al. Molecular Therapy-Oncolytics
- Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
- (2020) Asmita Pal et al. Frontiers in Microbiology
- Long noncoding RNAs (lncRNAs) in cervical carcinogenesis: New molecular targets, current prospects
- (2020) Maria Luiza Tabosa de Carvalho Galvão et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles
- (2020) Zahra Sadat Razavi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Molecular landscape of recurrent cervical cancer
- (2020) Divya Adiga et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Biological activities of Ficus carica latex for potential therapeutics in Human Papillomavirus (HPV) related cervical cancers
- (2019) Arshia Ghanbari et al. Scientific Reports
- Correlation of human papillomavirus 16 and 18 with cervical cancer and their diagnosis methods in Iranian women: A systematic review and meta-analysis
- (2019) Mona Fani et al. CURRENT PROBLEMS IN CANCER
- The Human Papillomavirus (HPV) E1 protein regulates the expression of cellular genes involved in immune response
- (2019) Leonardo Josué Castro-Muñoz et al. Scientific Reports
- Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
- (2019) Marc Arbyn et al. Lancet Global Health
- Epidemiology and burden of HPV-related disease
- (2018) Beatriz Serrano et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- HPV: Molecular pathways and targets
- (2018) Shilpi Gupta et al. CURRENT PROBLEMS IN CANCER
- Human Papillomavirus Types 16 and 18 Early-expressed Proteins Differentially Modulate the Cellular Redox State and DNA Damage
- (2018) Alfredo Cruz-Gregorio et al. International Journal of Biological Sciences
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The human papillomavirus DNA helicase E1 binds, stimulates, and confers processivity to cellular DNA polymerase epsilon
- (2017) Michaelle Chojnacki et al. NUCLEIC ACIDS RESEARCH
- The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor
- (2017) Toni M. Brand et al. Science Signaling
- The human papillomavirus E7 oncoprotein as a regulator of transcription
- (2017) William K. Songock et al. VIRUS RESEARCH
- Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression
- (2017) Cody Warren et al. Viruses-Basel
- Direct HPV E6/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation
- (2017) Yiyu Zhang et al. Oncotarget
- The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor
- (2017) Toni M. Brand et al. Science Signaling
- High Resolution Spatial Mapping of Human Footprint across Antarctica and Its Implications for the Strategic Conservation of Avifauna
- (2017) Luis R. Pertierra et al. PLoS One
- Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering
- (2016) Addison V. Wright et al. CELL
- Current state in the development of candidate therapeutic HPV vaccines
- (2016) Andrew Yang et al. Expert Review of Vaccines
- Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53
- (2016) Denise Martinez-Zapien et al. NATURE
- Tempo and mode of genome evolution in a 50,000-generation experiment
- (2016) Olivier Tenaillon et al. NATURE
- ERK Signaling Pathway Is Involved in HPV-16 E6 but not E7 Oncoprotein-Induced HIF-1α Protein Accumulation in NSCLC Cells
- (2016) Fei Liu et al. ONCOLOGY RESEARCH
- Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells
- (2015) Sanja Stevanović et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
- (2015) Cornelia L Trimble et al. LANCET
- An updated evolutionary classification of CRISPR–Cas systems
- (2015) Kira S. Makarova et al. NATURE REVIEWS MICROBIOLOGY
- The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy
- (2015) Ketaki Ganti et al. Viruses-Basel
- HER2 as a novel therapeutic target for cervical cancer
- (2015) Doo-Yi Oh et al. Oncotarget
- In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response
- (2015) Masaud Shah et al. Scientific Reports
- The Role of Signaling Pathways in Cervical Cancer and Molecular Therapeutic Targets
- (2014) Joaquín Manzo-Merino et al. ARCHIVES OF MEDICAL RESEARCH
- Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting
- (2014) De-Wei Wu et al. CARCINOGENESIS
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- Inactivation of the Human Papillomavirus E6 or E7 Gene in Cervical Carcinoma Cells by Using a Bacterial CRISPR/Cas RNA-Guided Endonuclease
- (2014) E. M. Kennedy et al. JOURNAL OF VIROLOGY
- Human Papillomavirus E7 Oncoprotein Increases Production of the Anti-Inflammatory Interleukin-18 Binding Protein in Keratinocytes
- (2014) K. H. Richards et al. JOURNAL OF VIROLOGY
- Human Papillomavirus E6 Triggers Upregulation of the Antiviral and Cancer Genomic DNA Deaminase APOBEC3B
- (2014) Valdimara C. Vieira et al. mBio
- APOBEC-Mediated Cytosine Deamination Links PIK3CA Helical Domain Mutations to Human Papillomavirus-Driven Tumor Development
- (2014) Stephen Henderson et al. Cell Reports
- Expression of Suppressor of Cytokine Signaling 1 (SOCS1) Impairs Viral Clearance and Exacerbates Lung Injury during Influenza Infection
- (2014) Keer Sun et al. PLoS Pathogens
- A novel function of HPV16-E6/E7 in epithelial–mesenchymal transition
- (2013) Young-Suk Jung et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment
- (2013) Chunxia Ren et al. EUROPEAN JOURNAL OF CANCER
- Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection
- (2013) Asia Asiaf et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Immune alterations and immunotherapy prospects in head and neck cancer
- (2013) Vincent Varilla et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability
- (2013) K. Akagi et al. GENOME RESEARCH
- The Human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter
- (2013) Uzma A. Hasan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Landscape of genomic alterations in cervical carcinomas
- (2013) Akinyemi I. Ojesina et al. NATURE
- Structure Based Identification and Characterization of Flavonoids That Disrupt Human Papillomavirus-16 E6 Function
- (2013) Jonathan J. Cherry et al. PLoS One
- The E4 protein; structure, function and patterns of expression
- (2013) John Doorbar VIROLOGY
- The E5 proteins
- (2013) Daniel DiMaio et al. VIROLOGY
- The E1 proteins
- (2013) Monika Bergvall et al. VIROLOGY
- Ruthenium oligonucleotides, targeting HPV16 E6 oncogene, inhibit the growth of cervical cancer cells under illumination by a mechanism involving p53
- (2012) A Reschner et al. GENE THERAPY
- HPV16 Oncoproteins Induce MMPs/RECK-TIMP-2 Imbalance in Primary Keratinocytes: Possible Implications in Cervical Carcinogenesis
- (2012) Laura Beatriz da Silva Cardeal et al. PLoS One
- Influence of HPV16 E6/7 on the Expression of FGF2 and FGFR Type B in Cervical Carcinogenesis
- (2012) Ya-Min Cheng et al. Reproductive Sciences
- Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses
- (2012) M. L. Bagarazzi et al. Science Translational Medicine
- Solution Structure Analysis of the HPV16 E6 Oncoprotein Reveals a Self-Association Mechanism Required for E6-Mediated Degradation of p53
- (2012) Katia Zanier et al. STRUCTURE
- Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value
- (2012) Niladri Ganguly CELLULAR ONCOLOGY
- Construction of a Full Transcription Map of Human Papillomavirus Type 18 during Productive Viral Infection
- (2011) X. Wang et al. JOURNAL OF VIROLOGY
- Role of Calpain in the Formation of Human Papillomavirus Type 16 E1^E4 Amyloid Fibers and Reorganization of the Keratin Network
- (2011) J. Khan et al. JOURNAL OF VIROLOGY
- Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo
- (2011) I Ramachandran et al. ONCOGENE
- HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress
- (2010) Vonetta M Williams et al. Future Virology
- Beyond Cervical Cancer: Burden of Other HPV-Related Cancers Among Men and Women
- (2010) Anil K. Chaturvedi JOURNAL OF ADOLESCENT HEALTH
- E1^E4-mediated keratin phosphorylation and ubiquitylation: a mechanism for keratin depletion in HPV16-infected epithelium
- (2010) P. B. McIntosh et al. JOURNAL OF CELL SCIENCE
- Effects of chromium picolinate supplementation on the growth, carcass quality and gene expression of beef during the finishing period
- (2010) Liu Guifen et al. MOLECULAR BIOLOGY REPORTS
- Low- and high-risk human papillomavirus E7 proteins regulate p130 differently
- (2010) Lisa Barrow-Laing et al. VIROLOGY
- Selective targeting of HPV-16 E6/E7 in cervical cancer cells with a potent oncolytic adenovirus and its enhanced effect with radiotherapy in vitro and vivo
- (2009) Wei Wang et al. CANCER LETTERS
- Involvement of NF- B and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein
- (2009) S.-H. Kim et al. CARCINOGENESIS
- Phosphorylation of the Human Papillomavirus Type 16 E1^E4 Protein at T57 by ERK Triggers a Structural Change That Enhances Keratin Binding and Protein Stability
- (2009) Q. Wang et al. JOURNAL OF VIROLOGY
- Bap31 Is a Novel Target of the Human Papillomavirus E5 Protein
- (2008) J. A. Regan et al. JOURNAL OF VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started